Zobrazeno 1 - 10
of 18 486
pro vyhledávání: ''
Autor:
Renate B. Schnabel, Isabelle C. Van Gelder, Lukasz Szumowski, Harry J.G.M. Crijns, Günter Breithardt, Sakis Themistoclakis, Karl Wegscheider, Stephan Willems, G. André Ng, Axel Brandes, Laurent M. Haegeli, Hein Heidbuchel, Anna Suling, Panos E. Vardas, Nele Gessler, Katrin Borof, A. John Camm, Paulus Kirchhof, Andreas Goette, Lars Eckardt, Josef Kautzner
Publikováno v:
European heart journal
Willems, S, Borof, K, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Gessler, N, Goette, A, Haegeli, L M, Heidbuchel, H, Kautzner, J, Ng, G A, Schnabel, R B, Suling, A, Szumowski, L, Themistoclakis, S, Vardas, P, van Gelder, I C, Wegscheider, K & Kirchhof, P 2022, ' Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms : the EAST-AFNET 4 trial ', European Heart Journal, vol. 43, no. 12, pp. 1219-1230 . https://doi.org/10.1093/eurheartj/ehab593
European Heart Journal, 43(12), 1219-1230. Oxford University Press
Willems, S, Borof, K, Brandes, A, Breithardt, G, Camm, A J, Crijns, H J G M, Eckardt, L, Gessler, N, Goette, A, Haegeli, L M, Heidbuchel, H, Kautzner, J, Ng, G A, Schnabel, R B, Suling, A, Szumowski, L, Themistoclakis, S, Vardas, P, van Gelder, I C, Wegscheider, K & Kirchhof, P 2022, ' Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms : the EAST-AFNET 4 trial ', European Heart Journal, vol. 43, no. 12, pp. 1219-1230 . https://doi.org/10.1093/eurheartj/ehab593
European Heart Journal, 43(12), 1219-1230. Oxford University Press
Aims Clinical practice guidelines restrict rhythm control therapy to patients with symptomatic atrial fibrillation (AF). The EAST-AFNET 4 trial demonstrated that early, systematic rhythm control improves clinical outcomes compared to symptom-directed
Autor:
Carla Spazzolini, Isabelle Denjoy, Roel L.H.M.G. Spätjens, Peter J. Schwartz, Maria Christina Kotta, Paul A. Brink, Cristina Moreno, Kristina H. Haugaa, Sandrine R.M. Seyen, Maria Shkolnikova, Federica Dagradi, Lia Crotti, Marshall Heradien, Paul G.A. Volders, Silvia Castelletti, Matteo Pedrazzini
Publikováno v:
Eur Heart J
European Heart Journal, 42(46), 4743-4755. Oxford University Press
European Heart Journal, 42(46), 4743-4755. Oxford University Press
Aims Mutation type, location, dominant-negative I Ks reduction, and possibly loss of cyclic adenosine monophosphate (cAMP)-dependent I Ks stimulation via protein kinase A (PKA) influence the clinical severity of long QT syndrome type 1 (LQT1). Given
Autor:
Arif Al Nooryani, Tomasz Roleder, Balázs Berta, Juan F. Granada, Krzysztof Piotr Malinowski, Michael Magro, Enrico Fabris, Cyril Camaro, Javier Escaned, Floris Kauer, Holger Nef, Mark Kennedy, Hector Garcia Garcia, Sebastian Reith, Clemens von Birgelen, Fernando Rivero, Bruno Pereira, Renicus S Hermanides, Alexander Ijsselmuiden, Elvin Kedhi, Giuseppe De Luca, Wojciech Wojakowski, Fernando Alfonso
Publikováno v:
European Heart Journal, 42, 4671-4679
European heart journal, 42(45), 4671-4679. Oxford University Press
European Heart Journal, 42, 45, pp. 4671-4679
European heart journal, 42(45), 4671-4679. Oxford University Press
European Heart Journal, 42, 45, pp. 4671-4679
AimsThe aim of this study was to understand the impact of optical coherence tomography (OCT)-detected thin-cap fibroatheroma (TCFA) on clinical outcomes of diabetes mellitus (DM) patients with fractional flow reserve (FFR)-negative lesions.Methods an
Autor:
Gabriele G. Schiattarella, Rudolf A. de Boer, Laura M G Meems, Carolyn S.P. Lam, Coenraad Withaar
Publikováno v:
European Heart Journal
Heart failure (HF) with preserved ejection fraction (HFpEF) is a multifactorial disease accounting for a large and increasing proportion of all clinical HF presentations. As a clinical syndrome, HFpEF is characterized by typical signs and symptoms of
Autor:
Susan Dent, Michael G. Fradley, Avirup Guha, Daniel Addison, Alvaro Alonso, Maryam B. Lustberg, Neal L. Weintraub
Publikováno v:
European Heart Journal. 43:300-312
Aims The national incidence, risk factors, and associated mortality of atrial fibrillation (AF) in breast cancer patients are unknown. Methods and results Using the Surveillance, Epidemiology, and End Results-Medicare-linked database, we identified f
Autor:
Filippo Crea
Publikováno v:
European Heart Journal. 42:4405-4409
Autor:
Filippo Crea
Publikováno v:
European Heart Journal. 42:4197-4201
Autor:
Claus Jünger, Natalie Arnold, Andrea Falcke, Jürgen H. Prochaska, Sophie Moll, Thomas Münzel, Andreas Schulz, Philipp S. Wild, Manfred E. Beutel, Norbert Pfeiffer, Sabrina Kopp, Harald Binder, Christine Espinola-Klein, Arina J. ten Cate-Hoek, Marina Panova-Noeva, Gregor Buch, Lisa Eggebrecht, Karl J. Lackner, Stephan Grabbe
Publikováno v:
European Heart Journal, 42(40), 4157-4165. Oxford University Press
Aims Evidence regarding the health burden of chronic venous insufficiency (CVI), its clinical determinants, and impact on outcome is scarce. Methods and results Systematic phenotyping of CVI according to established CEAP (Clinical-Etiologic-Anatomic-
Autor:
Suzanne C. Cannegieter, Qingui Chen, Willem M. Lijfering, Vladimir Tichelaar, Myrthe M A Toorop
Publikováno v:
European Heart Journal, 42(40), 4126-+. OXFORD UNIV PRESS
European Heart Journal, 42(40), 4126-4137. OXFORD UNIV PRESS
European Heart Journal, 42(40), 4126-4137. Oxford University Press
European Heart Journal
European Heart Journal, 42(40), 4126-4137. OXFORD UNIV PRESS
European Heart Journal, 42(40), 4126-4137. Oxford University Press
European Heart Journal
Aims Persistence with direct oral anticoagulants (DOACs) has become a concern in non-valvular atrial fibrillation (NVAF) patients, but whether this affects prognosis is rarely studied. We investigated the persistence with oral anticoagulants (OACs) a
Autor:
Anders Berg Wulff, Benjamin Nilsson Wadström, Børge G. Nordestgaard, Kasper Mønsted Pedersen, Gorm B. Jensen
Publikováno v:
Wadström, B N, Wulff, A B, Pedersen, K M, Jensen, G B & Nordestgaard, B G 2022, ' Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke : a cohort-based study ', European Heart Journal, vol. 43, no. 34, pp. 3258-3269 . https://doi.org/10.1093/eurheartj/ehab705
Aims The atherogenic potential of cholesterol in triglyceride-rich lipoproteins, also called remnant cholesterol, is being increasingly acknowledged. Elevated remnant cholesterol is associated with increased risk of myocardial infarction and ischaemi